Ignite Creation Date:
2024-05-06 @ 1:56 AM
Last Modification Date:
2024-10-26 @ 11:12 AM
Study NCT ID:
NCT01937390
Status:
COMPLETED
Last Update Posted:
2018-07-27
First Post:
2013-09-04
Brief Title:
Observational Study of Adherence to LABA LAMA in Chronic Obstructive Pulmonary Disease COPD
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
Post-Marketing Observational Study of the Impact of Adherence to Treatment With Once-Daily Administered Long-Acting Bronchodilators LABAs LAMAs on Patients Health Related Quality of Life in COPD Patients
Status:
COMPLETED
Status Verified Date:
2017-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of the study is to observe the effect of adherence to once-daily administered long-acting bronchodilators long-acting ß2-agonists LABAs long-acting muscarinic antagonists LAMAs on patients health related quality of life HR-QoL and to assess the relation between symptoms improvement and adherence to Chronic Obstructive Pulmonary Disease COPD maintenance therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None